Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.2800
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Trevena Market Cap
Trevena has a market cap or net worth of $268.46 thousand as of August 15, 2025. Its market cap has decreased by -96.24% in one year.
Market Cap
268.46K
Enterprise Value
24.37M
Revenue
546.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.28
Market Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 268.46K, a decrease of -99.84%. That is a compound annual growth rate of -42.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 268.46K | -79.28% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | 336.04M | 331.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |